Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

 

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

This Might Also Be of Your Interest

15 Mar 2022

An Eye on the Future of Preservative-Free Drops

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
22 Dec 2021

The Go-To Drug Delivery Expert

Brochures, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions

Read More
22 Dec 2021

End-To-End Support at Every Stage of Your Drug Development Journe...

Brochures, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions

Read More
13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital ...

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 2 3 5
Back To Top